<DOC>
	<DOCNO>NCT02357849</DOCNO>
	<brief_summary>We conduct randomize , 24-week , double-blind study , compare fluoxetine aripiprazole 48 patient attenuate positive symptom level least moderate severity .</brief_summary>
	<brief_title>Fluoxetine v Aripiprazole Comparative Trial ( FACT )</brief_title>
	<detailed_description>To Compare Fluoxetine Aripiprazole All-cause Discontinuation/Need Add Another Psychiatric Medication , Symptomatic Improvement , Adverse Effects</detailed_description>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>consent obtain patient parent ( assent patient 18 ) ; age 1225 year ( inclusive ) ; Englishspeaking ; least one positive ( Scale A ) SOPS score 35 , i.e. , moderate , moderately severe severe . lifetime diagnosis Axis I psychotic disorder , include : schizophreniform disorder , schizophrenia , schizoaffective disorder , bipolar disorder , major depression psychotic feature ; current psychosis ( positive symptom SOPS score 6 , i.e. , extreme ) ; current diagnosis Major Depressive Disorder , single episode recurrent , severe without psychotic feature ; current stimulant treatment ; history neurological , neuroendocrine medical condition know affect brain ; significant medical condition contraindicate treatment either aripiprazole fluoxetine ; past current substance dependence ; sunstance abuse within last 4 week ; IQ &lt; 70 .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>